<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        0212200305
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2020
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        Xoria
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        ADENOSINE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        3
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg/ml
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Intravenous use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Solution for injection
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        2
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        6
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Ampoule
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        110
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="HIKMA ITALIA SPA" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            HIKMA ITALIA SPA
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 441]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Jazeera Pharmaceutical Industries (JPI)
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            Jazeera Pharmaceutical Industries (JPI)
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        C01EB10
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Xoria contains a medicine called adenosine. This belongs to a group of medicines called&nbsp;&lsquo;antiarrhythmics&rsquo;.<br />Xoria works by slowing down electrical impulses between the upper and lower chambers of the heart.&nbsp;This slows the fast or uneven heartbeats called &lsquo;arrhythmias&rsquo;.<br /><strong>Xoria is used:</strong></p><ul><li>&nbsp;During a test. This is to help doctors find out what type of arrhythmia (uneven heart beat) you&nbsp;have</li><li>&nbsp;To bring your heart beat back to normal if you have a type of arrhythmia called &lsquo;paroxysmal&nbsp;supraventricular tachycardia (SVT)&rsquo; or &lsquo;Wolff-Parkinson-White Syndrome&rsquo;</li></ul><p><strong>In children, Xoria bolus is&nbsp;used:</strong></p><ul><li>To bring your child&rsquo;s heart beat back to normal if your child has a type of heart rhythm trouble&nbsp;called &lsquo;paroxysmal supraventricular tachycardia&rsquo; (PSVT)</li></ul>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Do not have Xoria if:</strong></p><ul><li>You are allergic (hypersensitive) to adenosine or any of the other ingredients of Xoria (listed in section 6 below).&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; Signs of an allergic reaction include: a rash, swallowing or breathing problems, swelling of your lips, face, throat or tongue</li><li>You have asthma or any other severe breathing problem</li><li>You have very low blood pressure (severe hypotension)</li><li>You have a type of heart failure where your heart is not pumping out enough blood</li><li>You have problems with your heart rhythm and do not have a pace maker (second or third degree AtrioVentricular block, sick sinus syndrome)</li><li>You have been told you have &lsquo;Long QT syndrome&rsquo;. This is a rare heart problem that can lead to a fast heart beat and fainting</li></ul><p>Do not have this medicine if any of the above apply to you.<br />If you are not sure, talk to your doctor, nurse or pharmacist before you are given Xoria.</p><p><strong>Warnings and Precautions</strong><br />Take special care with Xoria. Check with your doctor, nurse or pharmacist before you have Xoria if:</p><ul><li>You have a certain type of unusual heart rhythm (atrialfibrillation or atrial &not;utter) and in particular if you have an&lsquo;accessory conduction pathway&rsquo;</li><li>You have been told that you have a heart problem whereby the electrical impulses in parts of your heart take longer than normal to discharge and then recharge (prolonged QT interval)</li><li>You have low blood volume (hypovolaemia) that is not adequately corrected by treatment with medicines</li><li>You have problems with a part of your nervous system called the &lsquo;autonomic nervous system&rsquo;</li><li>You have narrowing of the main arteries in the neck (carotid artery). This means that not enough blood is getting to the brain (cerebrovascular insufficiency)</li><li>You have or have ever had fits or convulsions</li><li>You have difficulty in breathing (bronchospasm)</li><li>You have heart disease due to narrowing of your heart valves (stenotic valvular heart disease)</li><li>You have inflammation of the membrane surrounding your heart (pericarditis) or a build-up of fluid around your heart (pericardial effusion)</li><li>&nbsp;You have a left-right shunt in your heart. This will mean blood goes directly from the left side of your heart to the right side</li><li>&nbsp;You have narrowing of the left main artery supplying blood to your heart (left main coronary stenosis)</li><li>You have had a recent heart attack, severe heart failure or you have had a heart transplant in the last year</li><li>You have any minor problem with your heart (first degree AtrioVentricular block or bundle branch block). These conditions may be temporarily aggravated when you are given Xoria</li></ul><p>If you get a very slow heartbeat (severe bradycardia), respiratory failure, a heart problem that can be fatal (asystole), severe chest pains (angina) or very low blood<br />pressure (severe hypotension), then treatment with Xoria should be stopped.</p><p>Talk to your doctor immediately if:</p><ul><li>You experience signs of stroke. This may present itself as a sudden numb or weak feeling in the face, arms, or legs. Other signs include feeling confused, problems with sight, walking, coordination or balance, problems in saying words or slurring of speech.</li><li>You experience signs of heart attack (myocardia infarction). Severe chest pain is the usual main symptom. The pain may also travel up into your jaw, and down your left arm, or down both arms. You may also sweat, feel sick, and feel faint. A small heart attack (myocardial infarction) occasionally happens without causing pain (a&lsquo;silent myocardial infarction&rsquo;). It may be truly pain-free, or sometimes the pain is mild and you may think it is just heartburn or &lsquo;wind&rsquo;.</li></ul><p><strong>If you are below 18 years of age</strong><br />In children with a heart rhythm trouble called &lsquo;Wolff-Parkinson-White (WPW) syndrome&rsquo;, Xoria bolus may cause some unexpected severely abnormal heart rhythm.<br />If you are not sure if any of the above apply to you, talk to your doctor or nurse before being given Xoria.<br /><strong>Taking or using other medicines</strong><br />Please tell your doctor, nurse or pharmacist if you are taking or have recently taken any other medicines. This includes medicines you buy without a prescription, including herbal medicines. This is because Xoria can affect the way some other medicines work. Also, some medicines can affect the way Xoria works.<br />In particular, check with your doctor, nurse or pharmacist if you are taking any of the following:</p><ul><li>Dipyridamole (medicine used to thin the blood). Make sure your doctor knows you are taking dipyridamole. Your doctor may decide you should not have Xoria or may tell you to stop taking dipyridamole 24 hours before you are given Xoria or may need to give you a lower dose of Xoria.</li><li>Aminophylline or theophylline (medicines used to help breathing) Your doctor may tell you to stop taking it 24 hours before you are given Xoria.</li><li>Caffeine (sometimes found in headache medicines)</li></ul><p><strong>Taking Xoria with food and drink</strong></p><p>Food and drinks containing caffeine such as tea, coffee, chocolate and cola should be avoided for at least 12 hours before you are given Xoria.</p><p><strong>Pregnancy and breast-feeding</strong><br />Talk to your doctor or nurse before having this medicine if:</p><ul><li>You are pregnant, might become pregnant, or think that you may be pregnant. You should not be given Xoria if you are pregnant or think you may be pregnant, unless clearly necessary.</li><li>You are breast-feeding. You should not be given Xoria if you are breast-feeding.</li></ul><p>Ask your doctor or nurse for advice before taking any medicine if you are pregnant or breast-feeding.<br /><strong>Xoria contains sodium</strong><br />Xoria contains sodium. This should be taken into consideration by patients on a controlled sodium diet.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>How Xoria is given</strong></p><ul><li>Xoria is a medicine for use in hospitals.</li><li>It will be given to you by a doctor or nurse as an injection into your vein.</li><li>Your heart and blood pressure will be closely monitored.</li></ul><p><strong>How much Xoria is given</strong><br />If you are not sure why you are being given Xoria or have any questions about how much Xoria is being given to you, speak to your doctor, nurse or pharmacist.<br /><strong>Adults (including the elderly)</strong></p><ul><li>&nbsp;The first dose is 3 mg given over 2 seconds. This is given by rapid injection into your vein</li><li>&nbsp;If the first dose does not bring your heart beat to normal, then you will be given a second dose. The second dose is 6 mg given as a rapid injection.</li><li>If the second dose does not bring your heart beat to normal, then you will be given a third dose: The third dose is 12 mg given as a rapid injection</li><li>You should not have any more doses after the 12 mg dose</li></ul><p><strong>Infants and Children</strong><br />Xoria bolus is a medicine for use in hospitals with resuscitation equipment available.<br />Your child&rsquo;s doctor will decide if this medicine is needed, how much should be given depending on your child&rsquo;s weight, and if several injections are needed.</p><ul><li>Your child will be closely monitored, including recording of his/her heart&rsquo;s electrical activity using an ECG (electrocardiogram) machine.</li><li>It will be given as an injection into your child vein by a doctor or nurse.</li></ul><p><strong>If you have more Xoria than you should</strong><br />As this medicine is given to you by a doctor or nurse it is unlikely that you will be given too much. Your doctor will carefully work out how much Xoria you should be given.<br />If you have more of this medicine than you should, the following effects may happen:</p><ul><li>Very low blood pressure (severe hypotension)</li><li>Slow heartbeat (bradycardia)</li><li>A heart problem (asystole)&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;</li></ul><p>Your doctor will be monitoring your heart throughout the procedure.</p><p>As the length of time adenosine stays in the blood is very short, any side effects of too much Xoria would quickly stop when the injection is stopped. Sometimes you may need an injection of a medicine called aminophylline or theophylline to help with any side effects.<br />If you have any further questions on the use of this medicine, ask your doctor, nurse or pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, adenosine can cause side effects, although not everybody gets them. While you are being given adenosine you may have some of the following side effects:<br /><strong>If any of the following side effects get worse, tell your doctor or nurse and they may stop the injection:&nbsp;</strong></p><p>The side effects normally settle within seconds or minutes after the injection is finished but you should tell your doctor or nurse if any of them happen.<br /><strong>Very common</strong> (affects more than 1 person in 10)</p><ul><li>Reddening of skin with a feeling of heat (flushing)</li><li>Slow heartbeat (bradycardia)</li><li>Skipped heart beats or extra heartbeats</li><li>A heart problem called an AV block</li><li>Severe heart problems which can be fatal (asystole) or uneven heartbeat</li><li>Shortness of breath or the urge to breathe deeply (dyspnoea)</li><li>Chest pain or pressure on the chest</li></ul><p><strong>Common</strong> (affects less than 1 person in 10)</p><ul><li>Feeling dizzy or light-headed</li><li>Feeling sick (nausea)</li><li>Headache</li><li>Unusual skin sensations such as burning</li><li>Feeling nervous</li></ul><p><strong>Uncommon</strong> (affects less than 1 person in 100)</p><ul><li>Blurred vision</li><li>Being aware of your heartbeat or feeling it &lsquo;racing&rsquo;</li><li>Metallic taste in your mouth</li><li>Breathing more quickly or more deeply than normal (hyperventilation)</li><li>Feeling pressure in your head, or weighed down in your arms</li><li>Feeling of general discomfort, weakness or pain</li><li>Sweating</li></ul><p><strong>Very rare </strong>(affects less than 1 person in 10000)</p><ul><li>Severe breathlessness or problems in breathing</li><li>Redness, pain or swelling at the site of injection</li><li>Feeling uncomfortable during the injection</li><li>Worsening of high blood pressure that affects the brain (intracranial hypertension)</li><li>Very slow, fast or uneven heartbeats</li><li>Severe bradycardia (very slow heartbeat)</li></ul><p><strong>Other side effects</strong></p><ul><li>Fainting</li><li>Fits (convulsions)</li><li>Being sick (vomiting)</li><li>Stopping breathing (respiratory arrest)</li></ul><p>If any of the above side effects get worse, tell your doctor or nurse and they may stop the injection. The side effects normally settle within seconds or minutes after the injection is finished but you should tell your doctor or nurse if any of them happen.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>This medicine will be kept by your doctor, nurse or pharmacist in a safe place where children cannot see or reach it.<br />Keep this medicine out of the sight and reach of children.<br />Do not store above 30 &deg;C. Do not refrigerate.<br />Store in the original package.<br />The product is for single use only and should be used straight away after opening. Any portion of the vial not used at once should be disposed of.<br />Do not use this medicine after the expiry date which is stated on the package after &ldquo;EXP&rdquo;. The expiry date refers to the last day of that month.<br />Do not use this medicine if you notice any particles in the solution or any discolouration before they give you the medicine. If the appearance of the medicine has changed, the vial must be thrown away.<br />Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>What Xoria contains</strong><br />The active substance is adenosine. Each 1 ml contains 3 mg adenosine.<br />The other ingredients are sodium chloride and water for injection.<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Xoria 6 mg/2 ml Solution for Injection is a clear colourless solution for injection in 3 ml type I clear glass ampoules with
a 12.75 mm diameter, with orange one-point-cut (OPC).
Pack size: 6 ampoules (2 ml).
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Marketing Authorization Holder</strong></p><p>Jazeera Pharmaceutical Industries<br />Al-Kharj Road<br />P.O. BOX 106229<br />Riyadh 11666, Saudi Arabia<br />Tel: + (966-11) 8107023, + (966-11) 2142472<br />Fax: + (966-11) 2078170<br />e-mail: jpimedical@hikma.com</p><p><strong>Manufacturer</strong></p><p>Hikma Italia S.P.A.<br />Viale Certosa, 10<br />27100 Pavia, Italy<br />Tel: + (39-0382) 1751844, + (39-0382) 1751801<br />Fax: + (39-0382) 422745</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                This leaflet was last revised in 12/2018; version number SA2.0.
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p>يحتوي إكزوريا على دواء يسمى أدينوسين. وينتمي إلى مجموعة أدوية&nbsp;تسمى &laquo; مضادات اضطراب النظم&raquo;.<br />يعمل إكزوريا من خلال إبطاء النبضات الكهربائية بين حجرات القلب العلوية والسفلية. يعمل ذلك على إبطاء ضربات القلب السريعة أو الغير&nbsp;منتظمة التي تسمى &laquo;اضطرابات النظم&raquo; .<br /><strong>يتم استخدام إكزوريا:</strong></p><ul><li>أثناء الاختبار الطبّي. وذلك لمساعدة الأطباء على اكتشاف نوع اضطراب النظم (ضربات القلب الغير منتظمة) التي لديك</li><li dir="rtl">لإعادة ضربات القلب لديك إلى وضعها الطبيعي إذا كنت مصابًا بنوع من اضطراب النظم يسمى &laquo;تسارع القلب فوق البطيني الانتيابي&raquo; أو &laquo;متلازمة وولف-باركنسون-وايت&raquo;.</li></ul><p><strong>في الأطفال، يتم استخدام بلعة إكزوريا:</strong></p><ul><li>لإعادة ضربات القلب لدى طفلك إلى وضعها الطبيعي إذا كان&nbsp;طفلك مصابًا بمشكلة في نظم القلب تسمى &laquo;تسارع القلب فوق البطيني الانتيابي&raquo;</li></ul>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p><strong>لا تقم بأخذ إكزوريا إذا:</strong></p><ul><li>كنت تعاني من حساسية (فرط الحساسية) اتجاه أدينوسين أو أي من المواد الأخرى المستخدمة في تركيبة إكزوريا (المذكورة في&nbsp;القسم 6 أدناه). تشمل علامات رد الفعل التحسسي: الطفح، مشاكل في البلع أو التنفس، تورم في الشفتين، الوجه، الحلق أو اللسان</li><li>كنت مصابًا بالربو أو أي مشكلة تنفسية شديدة أخرى</li><li>كنت تعاني من ضغط دم منخفض للغاية (انخفاض ضغط الدم الشديد)</li><li>كنت تعاني من نوع من فشل القلب حيث أن قلبك لا يقوم بضخ كمية كافية من الدم</li><li>كنت تعاني من مشاكل في نظم القلب وليس لديك منظم ضربات القلب (إحصار أذيني بطيني من الدرجة الثانية أو الثالثة، متلازمة العقدة الجيبية المريضة)</li><li>قيل لك أنك تعاني &laquo;متلازمة طول فترةQT&raquo; &bull;هذه مشكلة قلبية نادرة قد تؤدي إلى سرعة ضربات القلب والإغماء لا تقم بأخذ هذا الدواء إذا كان ينطبق عليك أي من المذكور أعلاه. إذا لم تكن متأكدًا، فتحدث إلى طبيبك، الممرض أو الصيدلي قبل أن يتم إعطائك إكزوريا.</li></ul><p><strong>الاحتياطات والتحذيرات</strong><br />يجب التعامل بحرص بالغ مع إكزوريا. تحدث مع طبيبك، الممرض، أو&nbsp;الصيدلي قبل القيام بأخذ إكزوريا إذا:</p><ul><li dir="rtl">كنت تعاني من نوع معين من نظم القلب الغير طبيعية (الرجفان الأذيني&nbsp;أو الرفرفة الأذينية) وخاصة إذا كان لديك &laquo;مسار توصيل ملحق&raquo;</li><li dir="rtl">تم إخبارك بأنك تعاني من مشكلة في القلب تستغرق فيها النبضات&nbsp;الكهربائية في أجزاء من قلبك فترة أطول لتفريغها ثم إعادة شحنها (QTفترةطويلة)</li><li dir="rtl">&nbsp;كنت تعاني من انخفاض في حجم الدم (نقص حجم الدم) لم يتم علاجه بشكل صحيح باستخدام الأدوية.</li><li dir="rtl">&nbsp;كنت تعاني من مشاكل في جزء من جهازك العصبي يسمى &laquo;الجهاز العصبي اللاإرادي&raquo;.</li><li dir="rtl">تعاني من تضيق في الشرايين الرئيسية في الرقبة (الشريان السباتي). يعني ذلك عدم وصول كمية كافية من الدم إلى المخ (قصور وعائي دماغي)</li><li dir="rtl">كنت تعاني أو عانيت مسبقًا من نوبات أو اختلاجات</li><li dir="rtl">كنت تعاني من صعوبة في التنفس (التشنج القصبي)</li><li dir="rtl">كنت تعاني من مرض في القلب بسبب تضيق صمامات القلب (مرض تضيق صمامات القلب)</li><li dir="rtl">&nbsp;كنت تعاني من التهاب الغشاء المحيط بالقلب (التهاب التأمور) أو تراكم السوائل حول القلب (الانصباب التأموري)</li><li dir="rtl">&nbsp;كانت لديك تحويلة من اليسار إلى اليمين في القلب. يعني ذلك أن الدم&nbsp;سيتجه مباشرة من الجانب الأيسر لقلبك إلى الجانب الأيمن</li><li dir="rtl">&nbsp;كنت تعاني من تضيق الشريان الرئيسي الأيسر الذي يزود قلبك بالدّم&nbsp;(تضيق الشريان التاجي الرئيسي الأيسر)</li><li dir="rtl">كنت قد أصبت مؤخرًا بأزمة قلبية، فشل شديد في القلب أو خضعت&nbsp;لعملية زراعة قلب في العام الماضي</li><li dir="rtl">&nbsp;كنت تعاني من أي مشكلة بسيطة في القلب (إحصار أذيني بطيني من الدرجة الأولى أو إحصار الحزيمة). قد تتفاقم هذه الحالات بصورة&nbsp;مؤقتة عند إعطائك إكزوريا إذا عانيت من ضربات قلب بطيئة للغاية (بطء القلب الشديد)، قصور&nbsp;تنفسي، مشكلة في القلب قد تكون مميتة (توقف الانقباض)، آلام شديدة&nbsp;في الصدر (ذبحة صدرية)&nbsp;أو ضغط دم منخفض للغاية (انخفاض ضغط&nbsp;الدم الشديد)، يجب إيقاف العلاج باستخدام إكزوريا.</li></ul><p>تحدث إلى طبيبك على الفور إذا:</p><ul><li>&nbsp;تعرّضت إلى علامات السكتة الدماغية. قد يظهر هذا على شكل&nbsp;شعور خدران مفاجئ أو شعور بضعف في الوجه، أو الذراعين،&nbsp;أو الساقين. تشمل العلامات الأخرى الشعور بالارتباك، مشاكل في&nbsp;البصر أو المشي، أو التنسيق أو التوازن، أو مشاكل في قول الكلمات&nbsp;أو إهمال الكلام.</li><li dir="rtl">&nbsp;تعرّضت إلى علامات النوبة القلبية (احتشاء عضلة القلب). الألم الشديد&nbsp;في الصدر هو العرض الرئيسي المعتاد. قد ينتقل الألم أيضًا لديك&nbsp;إلى أعلى الفك، وأسفل ذراعك الأيسر، أو أسفل الذراعين. قد تعرق&nbsp;أيضًا، وتشعر بالغثيان، والإغماء. تحدث نوبة قلبية صغيرة (احتشاء&nbsp;عضلة القلب)&nbsp; من حين لآخر دون أن تسبب ألم (&laquo;احتشاء عضلة القلب الصامت&raquo;).&nbsp;قد تكون خالية من الألم حقًا، أو في بعض الأحيان يكون&nbsp;الألم خفيفًا وقد تعتقد أنه مجرد حرقة أو&nbsp; &laquo;ريح&nbsp;&raquo;.</li></ul><p><strong>إذا كان عمرك أقل من 18 عامًا</strong><br />في الأطفال المصابين بمشكلة في نظم القلب تسمى &laquo;متلازمة&nbsp;&laquo;ىوولف-&nbsp;باركنسون-وايت&raquo;،&nbsp;قد تسبب بلعة إكزوريا نظم قلبية غير طبيعية<br />شديدة غير متوقعة.<br />إذا لم تكن متأكدًا من أن أي من المذكور أعلاه ينطبق عليك، فتحدث إلى&nbsp;الطبيب أو الممرض قبل القيام بإعطائك إكزوريا.<br /><strong>تناول أو استخدام أدوية أخرى</strong><br />أخبر الطبيب، الممرض أو الصيدلي إذا كنت تتناول أو تناولت مؤخراً&nbsp;أية أدوية أخرى. ويشمل ذلك الأدوية التي تحصل عليها بدون وصفة&nbsp;طبية، بما في ذلك الأدوية العشبية. ذلك لأن إكزوريا قد يؤثر على&nbsp;طريقة عمل بعض الأدوية الأخرى. وأيضا بعض الأدوية قد تؤثر على&nbsp;طريقة عمل إكزوريا.<br />راجع الطبيب، الممرض أو الصيدلي إذا كنت تتناول أيًّا مما يلي على&nbsp;وجه الخصوص:</p><ul><li>ديبيريدامول (دواء يستخدم لترقيق الدم). احرص على أن يعلم الطبيب&nbsp;أنك تتناول ديبيريدامول. قد يقرر طبيبك أنه لا ينبغي عليك أخذ إكزوريا أو قد يطلب منك التوقف عن تناول ديبيريدامول قبل 24 ساعة&nbsp;من إعطائك إكزوريا أو قد يحتاج إلى إعطائك جرعة أقل من إكزوريا.</li><li>أمينوفيلين أو ثيوفيلين (أدوية تستخدم للمساعدة على التنفس). قد يطلب&nbsp;منك طبيبك التوقف عن تناولها قبل 24 ساعة من إعطائك إكزوريا</li><li dir="rtl">الكافيين (يوجد أحيانًا في أدوية الصداع)</li></ul><p><strong>إكزوريا مع الطعام والشراب</strong><br />ينبغي تجنب الأطعمة والمشروبات التي تحتوي على الكافيين مثل&nbsp;الشاي، القهوة، الشوكولاتة والكولا لمدة 12 ساعة على الأقل قبل&nbsp;إعطائك إكزوريا.<br /><strong>الحمل والرضاعة</strong><br />تحدث إلى طبيبك أو الممرض قبل أخذ هذا الدواء إذا:</p><ul><li>كنتِ حاملً، قد تصبحين حاملً أو تعتقدين أنكِ قد تكوني حاملاً. ينبغي&nbsp;عدم إعطائك إكزوريا إذا كنتِ حاملاً أو تعتقدين أنكِ قد تكوني حاملاً،&nbsp;ما لم يكن ذلك ضروريًا بشكل واضح</li><li dir="rtl">إذا كنتِ ترضعين طبيعيًا. ينبغي عدم إعطائك إكزوريا إذا كنتِ&nbsp;ترضعين طبيعياَ&nbsp;قم بطلب نصيحة طبيبك أو الممرض قبل تناول أي دواء إذا كنتِ حاملاً&nbsp;أو ترضعين طبيعياً.</li></ul><p><strong>يحتوي إكزوريا على الصوديوم</strong><br />يحتوي إكزوريا على الصوديوم. ينبغي على المرضى الذين يخضعون&nbsp;لنظام غذائي منخفض الصوديوم أخذ ذلك في الاعتبار.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p><strong>كيف يتم إعطاء إكزوريا</strong></p><ul><li>&nbsp;إكزوريا هو دواء مخصص للاستخدام في المستشفيات</li><li>&nbsp;سيقوم الطبيب أو الممرض بإعطائه لك كحقنة في الوريد</li><li>&nbsp;سيتم مراقبة قلبك وضغط الدم لديك عن كثب</li></ul><p><strong>ما الكمية المعطاة من إكزوريا</strong><br />إذا لم تكن متأكدًا من سبب إعطائك إكزوريا أو لديك أسئلة حول&nbsp;كمية إكزوريا التي يتم إعطائك إياها، فتحدّث إلى طبيبك، الممرض&nbsp;أو الصيدلي.<br /><strong>البالغون (بمن فيهم كبار السن)</strong></p><ul><li>تبلغ الجرعة الأولى 3 ملغم تُعطى على مدة ثانيتين. ويتم إعطائها&nbsp;بالحقن السريع في وريدك</li><li>إذا لم تنجح الجرعة الأولى في إعادة ضربات القلب لديك إلى وضعها&nbsp;الطبيعي، فسيتم إعطائك جرعة ثانية. تبلغ الجرعة الثانية 6 ملغم&nbsp;تُعطى كحقنة سريعة</li><li>إذا لم تنجح الجرعة الثانية في إعادة ضربات القلب لديك إلى وضعها&nbsp;الطبيعي، فسيتم إعطائك جرعة ثالثة: تبلغ الجرعة الثالثة 12 ملغم&nbsp;تُعطى كحقنة سريعة</li><li>ينبغي عدم إعطائك أي جرعات أخرى بعد جرعة ال 12 ملغم</li></ul><p><strong>الرضع والأطفال</strong><br />بلعة إكزوريا هي دواء مخصص للاستخدام في المستشفيات التي تتوفر&nbsp;فيها أجهزة إنعاش&nbsp;&nbsp;سيقرر طبيبك ما إذا كان طفلك بحاجة لهذا الدواء، مقدار الجرعة تبعًا&nbsp;لوزن طفلك وما إذا كان بحاجة لإعطاء عدة حقن.</p><ul><li>سيتم مراقبة طفلك عن كثب، وذلك يشمل تسجيل النشاط الكهربائي&nbsp;لقلبه/لقلبها باستخدام جهاز مخطط كهربية القلب</li><li>سيقوم الطبيب أو الممرض بإعطائه لطفلك كحقنة في الوريد.</li></ul><p><strong>إذا أخذت جرعة زائدة من إكزوريا</strong><br />يُعطى هذا الدواء بواسطة طبيب أو ممرض، لذلك من غير المحتمل&nbsp;أن يتم إعطائك جرعة زائدة منه. سيحدد طبيبك بعناية مقدار إكزوريا&nbsp;الذي ينبغي إعطائه لك.<br />إذا تم إعطائك جرعة زائدة من هذا الدواء، فقد تحدث الآثار التالية:</p><ul><li>انخفاض كبير لضغط الدم (انخفاض ضغط الدم الشديد)</li><li>ضربات قلب بطيئة (بطء القلب)</li><li>مشكلة في القلب (توقف الانقباض)</li></ul><p>سوف يقوم طبيبك بمراقبة قلبك أثناء الإجراء.<br />نظرًا لأن فترة بقاء أدينوسين في الدم قصيرة جدًا، فإن أي آثار جانبية&nbsp;للجرعة الزائدة من إكزوريا ستتوقف سريعًا عند إيقاف الحقن. قد تحتاج&nbsp;أحيانًا إلى حقنة من دواء يسمى أمينوفيلين أو ثيوفيلين للمساعدة على&nbsp;التغلب على أي آثار جانبية.<br />إذا كان لديك أية أسئلة إضافية حول استخدام هذا الدواء، يرجى استشارة&nbsp;طبيبك، الممرض أو الصيدلي.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p>مثل جميع الأدوية، قد يسبب أدينوسين بآثارًا جانبيةً، إلا أنه ليس&nbsp;بالضرورة أن تحدث لدى جميع مستخدمي هذا الدواء. قد تتعرض لبعض&nbsp;من الآثار الجانبية التالية أثناء إعطائك أدينوسين:<br /><strong>يُرجى إخبار طبيبك أو الممرض في حال أصبحت أي من الآثار الجانبية&nbsp;التالية أكثر سوءاً، وقد يقوموا بإيقاف الحقن</strong>:<br />تستقر الآثار الجانبية عادة خلال ثوانٍ أو دقائق بعد انتهاء الحقن لكن&nbsp;ينبغي عليك إخبار طبيبك أو الممرض إذا حدثت أي منها.<br /><strong>شائعة جدًا </strong>(تؤثر على أكثر من شخص من كل 10 أشخاص)</p><ul><li>احمرار الجلد مع الشعور بالحرارة (تورّد)</li><li>ضربات قلب بطيئة (بطء القلب)</li><li>ضربات قلب تم تخطيها أو زيادة في ضربات القلب</li><li>مشكلة بالقلب تسمى انسداد الصمام الشرياني الوريدي</li><li>مشاكل شديدة بالقلب والتي قد تكون مميتة (توقف الانقباض) أو عدم انتظام ضربات القلب</li><li>انقطاع النفس أو الشعور بحاجة ملحة للتنفس بعمق (الزلة التنفسية)</li><li>ألم بالصدر أو ضغط على الصدر</li></ul><p><strong>شائعة </strong>(تؤثر على أقل من شخص من كل 10 أشخاص)</p><ul><li>الشعور بالدوخة أو بالدوار.</li><li>الشعور بالإعياء (الغثيان)</li><li>الصداع</li><li>إحساس غير معتاد بالجلد مثل الشعور بالحرق</li><li>الشعور بالعصبية</li></ul><p><strong>غير شائعة </strong>(تؤثر على أقل من شخص من كل 100 شخص)</p><ul><li>تَغَيُّمُ الرُّؤْيَة</li><li>الإحساس بضربات القلب أو الشعور بأنها &laquo; تتسارع&nbsp;&raquo;</li><li>مذاق معدني في الفم</li><li>التنفس بصورة أسرع وأعمق من المعتاد (فرط التنفس)</li><li>الشعور بضغط في رأسك، أو ثقل في ذراعيك</li><li>الشعور العام بالانزعاج، الضعف أو الألم</li><li>التعرق</li></ul><p><strong>نادرة جدًا</strong> (تؤثر على أقل من شخص من كل 10000 شخص)</p><ul><li>عدم القدرة على التنفس الشديد أو مشكلات في التنفس</li><li>احمرار، ألم أو تورم في موضع الحقن</li><li>الشعور بعدم الارتياح أثناء الحقن</li><li>تفاقم حالة ارتفاع ضغط الدم مما يؤثر على المخ (ارتفاع ضغط الدم داخل الجمجمة)</li><li>ضربات قلب بطيئة للغاية، سريعة أو غير منتظمة</li><li>بطء القلب الشديد (ضربات قلب بطيئة للغاية)</li></ul><p><strong>آثار جانبية أخرى</strong></p><ul><li>&nbsp;الإغماء</li><li>&nbsp;نوبات (اختلاجات)</li><li>&nbsp;الإصابة بالإعياء (القيء)</li><li>&nbsp;التوقف عن التنفس (توقف التنفس)</li></ul><p>إذا أصبحت أي من الآثار الجانبية السابقة أكثر سوءًا، أخبر طبيبك أو&nbsp;الممرض وقد يقوموا بإيقاف الحقن. تستقر الآثار الجانبية عادة خلال&nbsp;ثوانٍ أو دقائق بعد انتهاء الحقن لكن ينبغي عليك إخبار طبيبك أو&nbsp;الممرض إذا حدثت أي منها.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>سيقوم الطبيب، الممرض أو الصيدلي بحفظ هذا الدواء في مكان آمن&nbsp;بعيدًا عن مرأى ومتناول الأطفال.<br />احفظ هذا الدواء بعيداً عن مرأى ومتناول الأطفال.<br />لا تحفظ الدواء عند درجة حرارة أعلى من 30 &deg; مئوية. لا يحفظ&nbsp;داخل الثلاجة.<br />احفظ الدواء داخل عبوته الخارجية.<br />هذا المنتج مخصص للاستخدام مرة واحدة فقط وينبغي استخدامه بعد فتحه على الفور.&nbsp;يجب التخلص من أي جزء لم يتم استخدامه من&nbsp;القارورة على الفور.<br />لا تستخدم هذا الدواء بعد تاريخ انتهاء الصلاحية المذكور على العبوة&nbsp;الخارجية. يشير تاريخ انتهاء الصلاحية إلى اليوم الأخير من ذلك الشهر.<br />لا تستخدم هذا الدواء إذا لاحظت أي جسيمات في المحلول أو أي تغير في&nbsp;اللون قبل إعطائك الدواء. إذا تغير شكل الدواء، يجب التخلص من القارورة.<br />لا تتخلص من الأدوية عن طريق مياه الصرف الصحي أو النفايات المنزلية. اسأل الصيدلي عن كيفية التخلص من الأدوية التي لم تعد بحاجة<br />إليها. اتبع هذه الإجراءات للحفاظ على سلامة البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p><strong>ما هي محتويات إكزوريا</strong><br />المادة الفعالة هي أدينوسين. يحتوي كل 1 مللتر على 3 ملغم أدينوسين.<br />المواد الأخرى المستخدمة في التركيبة التصنيعية هي كلوريد الصوديوم&nbsp;وماء معد للحقن.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p><strong>ما هو الشكل الصيدلاني لإكزوريا ووصفه وحجم عبوته</strong><br />إكزوريا 6 ملغم/2 مللتر محلول للحقن هو محلول شفاف عديم اللون&nbsp;مخصص للحقن في أمبولات زجاجية شفافة من النوع 1 بحجم 3 مللتر<br />وبقطر 12.75 ملمتر، بنقطة برتقالية محددة للكسر.</p><p>حجم العبوة: 6 أمبولات ( 2 مللتر).</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p>شركة الجزيرة للصناعات الدوائية<br />طريق الخرج<br />صندوق بريد 106229<br />الرياض 11666 ، المملكة العربية السعودية<br />هاتف: 8107023(11-966)+،&nbsp;2142472 (11-966)+ &nbsp;<br />فاكس: 2078170 (11-966)+<br />البريد الإلكتروني: <u>jpimedical@hikma.com</u><br /><strong>الشركة المصنعة</strong><br />شركة الحكمة إيطاليا<br />فيالي سيرتوزا، 10<br />27100 بافيا، إيطاليا<br />هاتف: 1751844 (0382-93) +،1751801 (0382-390)+<br />فاكس: 422745&nbsp;(0382-93)+<br />&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            2018/12  رقم النسخة .SA2.0
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Xoria 6 mg/2 ml Solution for Injection
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Each 1 ml contains 3 mg adenosine.

Excipient(s) with known effect: sodium.

For the full list of excipients, see section 6.1.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Solution for injection.

Clear colorless solution.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Rapid conversion to a normal sinus rhythm of paroxysmal supraventricular tachycardias, including those associated with accessory by‐pass tracts (Wolff‐Parkinson‐White Syndrome).&nbsp;</p><p><u>Paediatric population</u><br />Rapid conversion to a normal sinus rhythm of paroxysmal supraventricular tachycardia in children aged 0 to 18 years.</p><p><u>Diagnostic Indications</u><br />Aid to diagnosis of broad or narrow complex supraventricular tachycardias. Although Xoria will not convert atrial flutter, atrial fibrillation or ventricular tachycardia to sinus rhythm, the slowing of AV conduction helps diagnosis of atrial activity.<br />Sensitisation of intra‐cavitary electrophysiological investigations.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Xoria is intended for hospital use only with monitoring and cardiorespiratory resuscitation equipment available for immediate use.</p><p><strong><u>Method of administration</u></strong></p><p>It should be administered by rapid IV bolus injection according to the ascending dosage schedule below. To be certain the solution reaches the systemic circulation administer either directly into a vein or into an IV line. If given into an IV line it should be injected as proximally as possible, and followed by a rapid saline flush.<br />Xoria should only be used when facilities exist for cardiac monitoring. Patients who develop high‐level AV block at a particular dose should not be given further dosage increments.</p><p><strong><u>Posology</u></strong></p><p><u>Adult<em>:</em></u></p><p>Initial dose: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3 mg given as a rapid intravenous bolus (over 2 seconds).</p><p>Second dose: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If the first dose does not result in elimination of the supraventricular tachycardia within 1 to 2 minutes, 6mg should be given also as a&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; rapid intravenous bolus.</p><p>Third dose:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;If the second dose does not result in elimination of the supraventricular tachycardia within 1 to 2 minutes. 12 mg should be given also&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;as a rapid intravenous bolus.</p><p>Additional or higher doses are not recommended.</p><p><u>Paediatric population</u><br />During administration of adenosine cardio‐respiratory resuscitation equipment must be available for immediate use if necessary.<br />Adenosine is intended for use with continuous monitoring and ECG recording during administration.<br />The dosing recommended for the treatment of paroxysmal supraventricular tachycardia in the paediatric population is:</p><ul><li>First bolus of 0.1 mg/kg body weight (maximum dose of 6 mg)</li><li>Increments of 0.1 mg/kg body weight as needed to achieve termination of supraventriculartachycardia (maximum dose of 12 mg).</li></ul><p><u>Method of administration</u><br />Adenosine should be administered by rapid intravenous (IV) bolus injection into a vein or into an&nbsp;IV line. If given into an IV line it should be injected through as proximally as possible, and followed by a rapid saline flush. If administered through a peripheral vein, a large bore cannula should be used.</p><p><u>Elderly</u><br />See dosage recommendations for adults.</p><p><strong><u>Diagnostic dose</u></strong><br />The &nbsp; above &nbsp; ascending &nbsp; dosage &nbsp; schedule &nbsp; should &nbsp; be &nbsp; employed &nbsp; until &nbsp; sufficient &nbsp;&nbsp;diagnostic information has been obtained.<br />Method of administration: Rapid intravenous injection only.<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Xoria is contraindicated for patients presenting:
•  Known hypersensitivity to adenosine or to any of the excipients.
•  Sick sinus syndrome, second or third  degree  Atrio‐Ventricular (AV) block (except  in patients with a functioning artificial pacemaker).
•  Chronic obstructive lung disease with evidence of bronchospasm (e.g. asthma bronchiale)
•  Long QT syndrome
•  Severe hypotension
•  Decompensated states of heart failure

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Special warnings: Due to the possibility of transient cardiac arrhythmias arising during conversion of the supraventricular tachycardia to normal sinus rhythm, administration should be carried out in a hospital setting with monitoring and cardio‐respiratory resuscitation equipment available for immediate use if necessary. During administration, continuous ECG monitoring is necessary as life‐threatening arrhythmia might occur. (section 4.2).</p><p>Because it has the potential to cause significant hypotension, adenosine should be used with caution in patients with left main coronary stenosis, uncorrected hypovolemia, stenotic valvular heart disease, left to right shunt, pericarditis or pericardial effusion, autonomic dysfunction or stenotic carotid artery disease with cerebrovascular insufficiency. There have been reports of cerebrovascular accident/transient ischemic attack, secondary to the haemodynamic effects of adenosine.</p><p>Adenosine should be used with caution in patients with recent myocardial infarction, severe heart failure, or in patients with minor conduction defects (first degree A‐V block, bundle branch block) that could be transiently aggravated during infusion.</p><p>Adenosine should be used with caution in patients with atrial fibrillation or flutter and especially in those with an accessory by‐pass tract since particularly the latter may develop increased conduction down the anomalous pathway.</p><p>Rare &nbsp;cases &nbsp;of &nbsp;severe &nbsp;bradycardia &nbsp;have &nbsp;been &nbsp;reported. &nbsp;Some &nbsp;occurred &nbsp;in &nbsp;early &nbsp;post &nbsp;heart transplant patients; in the other cases, occult sino‐atrial disease was present. The occurrence of&nbsp;severe &nbsp;bradycardia &nbsp;should &nbsp;be &nbsp;taken &nbsp;as &nbsp;a &nbsp;warning &nbsp;of &nbsp;underlying &nbsp;disease &nbsp;and &nbsp;could potentially favour the occurrence of torsades de pointes, especially in patients with prolonged QT&nbsp;intervals.</p><p>In &nbsp;patients &nbsp;with &nbsp;recent &nbsp;heart &nbsp;transplantation &nbsp;(less &nbsp;than &nbsp;1 &nbsp;year) &nbsp;an &nbsp;increased sensitivity &nbsp;of &nbsp;the heart to adenosine has been observed.</p><p>Since neither the kidney nor the liver are involved in the degradation of exogenous adenosine,&nbsp;Adenosine&#39;s efficacy should be unaffected by hepatic or renal insufficiency.</p><p>As &nbsp;dipyridamole &nbsp;is &nbsp;a &nbsp;known &nbsp;inhibitor &nbsp;of &nbsp;adenosine &nbsp;uptake, &nbsp;it &nbsp;may &nbsp;potentiate &nbsp;the &nbsp;action&nbsp;&nbsp;of adenosine. &nbsp;It &nbsp;is &nbsp;therefore &nbsp;suggested &nbsp;that &nbsp;adenosine should &nbsp;not &nbsp;be &nbsp;administered &nbsp;to patients receiving &nbsp;dipyridamole; &nbsp;if &nbsp;use &nbsp;of &nbsp;adenosine &nbsp;is &nbsp;essential, &nbsp;dipyridamole &nbsp;should &nbsp;be&nbsp;stopped &nbsp;24 hours &nbsp;before hand, &nbsp;or &nbsp;the &nbsp;dose &nbsp;of &nbsp;adenosine &nbsp;should &nbsp;be &nbsp;greatly &nbsp;reduced. &nbsp;(<em>see &nbsp;Section &nbsp;4.5 Interactions with other Medicaments and other forms of Interaction</em>).&nbsp;</p><p><em>Precautions:</em><br />The &nbsp; occurrence &nbsp; of &nbsp; angina, &nbsp; severe &nbsp; bradycardia, &nbsp; severe &nbsp; hypotension, &nbsp; respiratory failure (potentially &nbsp;fatal), &nbsp; or &nbsp; asystole/cardiac &nbsp; arrest &nbsp; (potentially &nbsp; fatal), &nbsp; should lead &nbsp; to &nbsp; immediate discontinuation of administration.</p><p>Adenosine &nbsp;may &nbsp;trigger &nbsp;convulsions &nbsp;in &nbsp;patients &nbsp;who &nbsp;are &nbsp;susceptible &nbsp;to &nbsp;convulsions. &nbsp;In patients with &nbsp; history &nbsp;of &nbsp; convulsions/seizures, &nbsp; the &nbsp; administration &nbsp; of &nbsp; adenosine &nbsp;&nbsp;should &nbsp;be &nbsp; carefully monitored.</p><p>Because of the possible risk of torsades de pointes, Xoria should be used with caution in patients&nbsp;with &nbsp;a &nbsp;prolonged &nbsp;QT &nbsp;interval, &nbsp;whether &nbsp;this &nbsp;is &nbsp;drug induced &nbsp;or &nbsp;of &nbsp;metabolic &nbsp;origin. Xoria &nbsp;is contraindicated in patients with Long QT syndrome (see section 4.3).</p><p>Adenosine may precipitate or aggravate bronchospasm (see sections 4.3 and 4.8).</p><p>Adenosine contains sodium. To be taken into consideration by patients on a controlled sodium diet.</p><p><u>Paediatric population</u><br />Adenosine &nbsp;may &nbsp;trigger &nbsp;atrial &nbsp;arrhythmias &nbsp;and &nbsp;thus &nbsp;might &nbsp;lead &nbsp;to &nbsp;ventricular &nbsp;acceleration&nbsp;in children with Wolff‐Parkinson‐White (WPW) syndrome. Also see section 5.1.<br />The efficacy of intraosseus administration has not been established.<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Dipyridamole inhibits adenosine cellular uptake and metabolism, and potentiates the action of adenosine. &nbsp;In one &nbsp;study &nbsp;dipyridamole &nbsp;was &nbsp;shown &nbsp;to &nbsp;produce &nbsp;a &nbsp;4 &nbsp;fold &nbsp;increase &nbsp;in adenosine actions. Asystole has been reported following concomitant administration.</p><p>It is therefore &nbsp;suggested &nbsp;that &nbsp;adenosine &nbsp;should &nbsp;not &nbsp;be &nbsp;administered &nbsp;to &nbsp;patients receiving dipyridamole; if use of adenosine is essential, dipyridamole should be stopped 24 hours&nbsp;before hand, or the dose of adenosine should be greatly reduced. See Section 4.4 Special Warnings&nbsp;and Precautions for Use.</p><p>Aminophylline, &nbsp;theophylline &nbsp;and &nbsp;other &nbsp;xanthines &nbsp;are &nbsp;competitive &nbsp;adenosine &nbsp;antagonists &nbsp;and&nbsp;should be avoided for 24 hours prior to use of adenosine.</p><p>Food and drinks containing xanthines (tea, coffee, chocolate and cola) should be avoided for at&nbsp;least 12 hours prior to use of adenosine.</p><p>Xoria may interact with drugs tending to impair cardiac conduction.<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Pregnancy</u><br />There are no or limited amount of data from the use of adenosine in pregnant women. Animal studies &nbsp;are &nbsp;insufficient &nbsp;with &nbsp;respect &nbsp;to &nbsp;reproductive &nbsp;toxicity. &nbsp;Adenosine &nbsp;is &nbsp;not &nbsp;recommended&nbsp;during pregnancy unless the physician considers the benefits to outweigh the potential risks.<br /><u>Lactation</u><br />It is unknown whether adenosine metabolites are excreted in human milk<br />Ademocor should not be used during breast‐feeding.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Adverse events are ranked under the heading of the frequency: Very common (&gt;1/10), Common (&gt;1/100, &nbsp; &lt;1/10), &nbsp; Uncommon &nbsp; (&gt;1/1000, &nbsp; &lt;1/100), &nbsp; Rare &nbsp; (&gt;1/10000, &nbsp; &lt;1/1000), &nbsp; Very &nbsp; rare&nbsp;(&lt;1/10000), Not known (cannot be estimated from available data).</p><p>These &nbsp;side &nbsp;effects &nbsp;are &nbsp;generally &nbsp;mild, &nbsp;of &nbsp;short &nbsp;duration &nbsp;(usually &nbsp;less &nbsp;than &nbsp;1 &nbsp;minute) and &nbsp;well tolerated by the patient. However severe reactions can occur.<br />Methylxanthines, &nbsp;such &nbsp;as &nbsp;IV &nbsp;aminophylline &nbsp;or &nbsp;theophylline &nbsp;have &nbsp; been &nbsp;used &nbsp;to &nbsp;terminate persistent side effects (50‐125 mg by slow intravenous injection).</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p><strong>Frequency</strong></p></td><td style="vertical-align:top"><p><strong><em>Applicable to Adenosine 6mg/2ml</em></strong></p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Immune system disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Not known</p></td><td style="vertical-align:top"><p>‐Anaphylactic reaction (including angioedema and skin reactions such as urticaria and rash).</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Cardiac Disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Very common</p></td><td style="vertical-align:top"><p>‐ Bradycardia</p><p>‐ Sinus pause, skipped beats</p><p>‐ Atrial extrasystoles</p><p>‐ Atrio‐Ventricular block</p><p>‐ Ventricular excitability disorders such as ventricular extrasystoles, non‐sustained ventricular tachycardia</p></td></tr><tr><td style="vertical-align:top"><p>Uncommon</p></td><td style="vertical-align:top"><p>‐ Sinus tachycardia</p><p>‐ Palpitations</p></td></tr><tr><td style="vertical-align:top"><p>Very rare</p></td><td style="vertical-align:top"><p>‐ Atrial fibrillation</p><p>‐ Severe bradycardia not corrected by atropine and possibly requiring temporary pacing</p><p>‐ Ventricular excitability disorders</p><p>Including ventricular fibrillation and torsade de pointes (see section 4.4)</p></td></tr><tr><td style="vertical-align:top"><p>Not known</p></td><td style="vertical-align:top"><p>‐ Hypotension sometimes severe</p><p>‐ asystole /Cardiac arrest, sometimes fatal especially in patients with underlying ischemic heart disease /cardiac disorder (see section 4.4)</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Nervous System disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Common</p></td><td style="vertical-align:top"><p>‐ Headache</p><p>‐ Dizziness, light‐headedness</p></td></tr><tr><td style="vertical-align:top"><p>Uncommon</p></td><td style="vertical-align:top"><p>‐ Head pressure</p></td></tr><tr><td style="vertical-align:top"><p>Very rare</p></td><td style="vertical-align:top"><p>‐Transient and hypertension spontaneously rapidly reversible worsening of intracranial</p></td></tr><tr><td style="vertical-align:top"><p>Not known</p></td><td style="vertical-align:top"><p>‐ Loss of consciousness / syncope</p><p>‐ Convulsions, especially in predisposed patients (see section 4.4)</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Eye disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Uncommon</p></td><td style="vertical-align:top"><p>‐ Blurred vision</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Respiratory, thoracic and mediastinal disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Very common</p></td><td style="vertical-align:top"><p>‐ Dyspnea (or the urge to take a deep breath)</p></td></tr></tbody></table><table border="1" cellspacing="0" cellpadding="0" style="width:873px"><tbody><tr><td style="vertical-align:top; width:99px"><p>Uncommon</p></td><td style="vertical-align:top; width:772px"><p>‐ Hyperventilation</p></td></tr><tr><td style="vertical-align:top; width:99px"><p>Very rare</p></td><td style="vertical-align:top; width:772px"><p>‐ Bronchospasm (see section 4.4)</p></td></tr><tr><td style="vertical-align:top; width:99px"><p>Not known</p></td><td style="vertical-align:top; width:772px"><p>‐ Respiratory failure (see section 4.4)</p><p>‐ Apnea / Respiratory arrest,</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p>Cases of Respiratory failure, bronchospasm, apnea, and respiratory arrest with fatal outcome have been reported.</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Gastrointestinal disorders</strong></p></td></tr><tr><td style="vertical-align:top; width:99px"><p>Common</p></td><td style="vertical-align:top; width:772px"><p>‐ Nausea</p></td></tr><tr><td style="vertical-align:top; width:99px"><p>Uncommon</p></td><td style="vertical-align:top; width:772px"><p>‐ Metallic taste</p></td></tr><tr><td style="vertical-align:top; width:99px"><p>Not known</p></td><td style="vertical-align:top; width:772px"><p>‐ Vomiting</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Vascular disorders</strong></p></td></tr><tr><td style="vertical-align:top; width:99px"><p>Very common</p></td><td style="vertical-align:top; width:772px"><p>‐ Flushing</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>General disorders and Administration Site conditions</strong></p></td></tr><tr><td style="vertical-align:top; width:99px"><p>Very common</p></td><td style="vertical-align:top; width:772px"><p>‐Chest pressure/pain, feeling of thoracic constriction/oppression</p></td></tr><tr><td style="vertical-align:top; width:99px"><p>Common</p></td><td style="vertical-align:top; width:772px"><p>‐ Burning sensation</p></td></tr><tr><td style="vertical-align:top; width:99px"><p>Uncommon</p></td><td style="vertical-align:top; width:772px"><p>‐ Sweating</p><p>‐ Feeling of general discomfort / weakness / pain</p></td></tr><tr><td style="vertical-align:top; width:99px"><p>Very rare</p></td><td style="vertical-align:top; width:772px"><p>‐ Injection site reactions</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Psychiatric disorders</strong></p></td></tr><tr><td style="vertical-align:top; width:99px"><p>Common</p></td><td style="vertical-align:top; width:772px"><p>‐ Apprehension</p></td></tr></tbody></table><p><u>Reporting of suspected adverse reactions</u></p><p>Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via:</p><ul><li>Saudi Arabia</li></ul><p>The National Pharmacovigilance Center (NPC)</p><p>Fax: + (966‐11) 2057662</p><p>Call NPC at: + (966‐11) 2038222, Exts: 2317‐2356‐2340.</p><p>SFDA Call Center: 19999</p><p>e‐mail:<u> npc.drug@sfda.gov.sa</u></p><p>Website: <u>https://ade.sfda.gov.sa/</u></p><ul><li>Other GCC States</li></ul><p>Please contact the relevant competent authority</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Overdosage would cause severe hypotension, bradycardia or asystole. The half life of adenosine in&nbsp;blood is very short, and side effects (when they occur) would quickly resolve. Administration of IV&nbsp;aminophylline or theophylline may be needed. Pharmacokinetic evaluation indicates that methyl xanthines are competitive antagonists to adenosine, and that therapeutic concentrations of theophylline block its exogenous effects.<br />&nbsp;</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: Other Cardiac Preparations: ATC Code: C01EB 10</p><p>Endogenous nucleoside with peripheral vasodilator/antiarrhythmic effect</p><p>Antiarrhythmic drug.</p><p>Adenosine is a purine nucleoside which is present in all cells of the body. Animal pharmacology studies have in several species shown that Adenosine has a negative dromotropic effect on the atrioventricular (AV) node.</p><p>In man Xoria (Adenosine) administered by rapid intravenous injection slows conduction through the AV node. This action can interrupt re‐entry circuits involving the AV node and restore normal sinus rhythm in patients with paroxysmal supraventricular tachycardias. Once the circuit has been interrupted, the tachycardia stops and normal sinus rhythm is re‐established.</p><p>One acute interruption of the circuit is usually sufficient to arrest the tachycardia.</p><p>Since atrial fibrillation and atrial flutter do not involve the AV node as part of a re‐entry circuit, Adenosine will not terminate these arrhythmias.</p><p>By transiently slowing AV conduction, atrial activity is easier to evaluate from ECG recordings and therefore the use of Adenosine can aid the diagnosis of broad or narrow complex tachycardias.</p><p>Adenosine may be useful during electrophysiological studies to determine the site of AV block or to determine in some cases of pre‐excitation, whether conduction is occurring by an accessory pathway or via the AV node.</p><p><u>Paediatric population</u><br />No controlled studies have been conducted in paediatric patients with adenosine for the conversion of paroxysmal supraventricular tachycardia (PSVT). However, the safety and efficacy of &nbsp;adenosine &nbsp;in &nbsp;children &nbsp;aged &nbsp;0 &nbsp;to &nbsp;18 &nbsp;years &nbsp;with &nbsp;PSVT &nbsp;is &nbsp;considered &nbsp;established &nbsp;based&nbsp;on extensive clinical use and literature data (open label studies, case reports, clinical guidelines).</p><p>Literature &nbsp;review &nbsp;identified &nbsp;14 &nbsp;studies &nbsp;where &nbsp;IV &nbsp;adenosine &nbsp;was &nbsp;used &nbsp;for &nbsp;acute &nbsp;termination &nbsp;of supraventricular tachycardia (SVT) in around a total of 450 paediatric patients&nbsp;aged 6 hours to 18 years. Studies were heterogenic in terms of age, and dosing schedules. SVT was&nbsp;terminated in 72 to 100% of cases in most of the published studies. Dosages used varied from 37.5&nbsp;mcg/kg to 400 mcg/kg. Several studies discussed a lack of response to starting doses less than&nbsp;100mcg/kg.</p><p>Depending on the child&#39;s clinical history, symptoms and ECG diagnosis, adenosine has been used in clinical &nbsp; practice &nbsp; under &nbsp; expert &nbsp; supervision &nbsp; in &nbsp; children &nbsp; with &nbsp; stable &nbsp; wide‐QRS complex tachycardia and Wolff‐Parkinson‐White syndrome however the currently available data does&nbsp;not support &nbsp;a &nbsp;paediatric &nbsp;indication. &nbsp;In &nbsp;total &nbsp;6 &nbsp;cases &nbsp;of &nbsp;adenosine‐induced &nbsp;arrhythmias (3 &nbsp;atrial fibrillation, 2 atrial flutter, 1 ventricular fibrillation) have been described in 6&nbsp;children aged 0 to 16 years with manifest or concealed WPW syndrome, of which 3 spontaneously&nbsp;recovered and 3 needed amiodarone +/‐ cardioversion (see also section 4.4).</p><p>Adenosine has &nbsp;been &nbsp;used as &nbsp;an &nbsp;aid &nbsp;to &nbsp;diagnosis &nbsp;of &nbsp;broad &nbsp;or narrow complex supraventricular&nbsp;tachycardias &nbsp; in &nbsp; same &nbsp; doses as &nbsp; for &nbsp; treatment &nbsp; of &nbsp; supraventricular &nbsp; tachycardia. &nbsp;&nbsp;Although adenosine &nbsp;will &nbsp;not &nbsp;convert &nbsp;atrial &nbsp;flutter, &nbsp;atrial &nbsp;fibrillation &nbsp;or ventricular &nbsp;tachycardia &nbsp;to &nbsp;sinus rhythm, the slowing of AV conduction helps diagnosis of atrial activity.&nbsp;However, the currently available data does not support a paediatric indication for the use of&nbsp;adenosine for diagnostic purposes.<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Adenosine is impossible to study via classical ADME protocols. It is present in various forms in all cells of the body where it plays an important role in energy production and utilisation systems.</p><p>An efficient salvage and recycling system exists in the body, primarily in the erythrocytes and blood vessel endothelial cells. The half‐life in vitro is estimated to be &lt;10 seconds. The in vivo half‐life may be even shorter.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>There are no pre‐clinical data of relevance to the prescriber which are additional to that already included in other sections of the SPC.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>‐ Sodium chloride<br />‐ Water for injection</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Compatibility with other medicines is not known.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                24 months

Any portion of the vial not used at once should be discarded.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Do not store above 30 ᵒC. Do not refrigerate.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>3 ml type I clear glass ampoules with a 12.75 mm diameter, with orange one‐point‐cut (OPC).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>None.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Jazeera Pharmaceutical Industries
Al‐Kharj Road
P.O. BOX 106229
Riyadh 11666, Saudi Arabia
Tel: + (966‐11) 8107023, + (966‐11) 2142472
Fax: + (966‐11) 2078170
e‐mail: jpimedical@hikma.com
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                11 December 2018
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>